Clinical Research Organization Audit for Good Clinical Practice

Instructor: Ronald Schoengold
Product ID: 700907
  • Duration: 90 Min
This Webinar defines the role of the CRO to ensure that each party is meeting its responsibilities. CRO audits ensure that the study data and results are credible and accurate, and that the rights and well-being of study subjects have been protected.

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section
Last Recorded Date: Aug-2008

Training CD / USB Drive

One CD/USB is for usage in one location only.
(For multiple locations contact Customer Care)
CD/USB and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-362-2367


Read Frequently Asked Questions

Why Should You Attend:

A Contract Research Organization (CRO) has specific responsibilities in auditing a clinical study for conformance with the applicable Good Clinical Practice (GCP) regulations. The CRO is required to certify conformance with the study design, conduct of the work, accuracy of recorded data and information, analysis of results and reports to FDA. CRO audits ensure that the study data and results are credible and accurate, and that the rights and well-being of study subjects have been protected. CRO audits also identify needed corrective and preventive actions. Government regulation of GCP protects human subjects who participate in clinical studies. FDA publishes specific GCP regulations based on the laws enacted by the Congress (amendments to the FD&C Act). These laws make the protection of clinical study subjects the joint responsibility of four independent parties, each with specific obligations:

  • Product Sponsor
  • Institutional Review Board
  • Clinical Investigator
  • FDA

Areas Covered in the seminar:

  • Pre-study Requirements and Start-Up:
    • Study Protocol
    • IRB
    • Investigator and Staff Credentials
    • Site Inspection
    • Control of Drug or Product
    • Data Management
    • Regulatory Binder
    • Standards of Procedures Binder
  • Ongoing Study Requirements:
    • Significant Safety Reports (Adverse Events)
    • Protocol Amendments
    • IRB Updates
    • Correspondence
    • New Safety Data
    • Monitor Visits (Case Report Forms Review)
    • Regulatory Binder Updates
    • Standards of Procedures Updates
  • Close-out Study Requirements:
    • Safety Data Report
    • Final IRB Report
    • Study Protocol Compliance
    • Correspondence
    • Data Management
    • Monitor Visits (Case Report Forms Review)
    • Record Retention Requirements
    • Possible FDA Inspection
    • NDA/PMA Filing Status
    • Drug or Product Supplies

Who will benefit:

  • Executive Management (Sponsor)
  • Sponsor Supported CRO
  • Regulatory Compliance Managers
  • Project and Program Managers
  • Product Development, R&D and Engineering Managers
  • Internal Auditors (Sponsor)
  • Quality Assurance Risk Management Manager
  • Information Technology/Data Management Personnel

Instructor Profile:

Ron Schoengold, is a private consultant to the biotechnology and medical device industry, offering the most current quality, technical and business information on how to commercialize and maintain medical products in a competitive environment. An active contributor to the industry for over 40 years, Ron has developed commercially successful screening and diagnostic products for gastroenterology, infectious disease and point-of-care testing. He serves as an advisor for the Larta Institute which is supported by the National Institutes of Health Commercialization Assistance Program to help companies awarded SBIR grants. Ron has published, presented or contributed to more than 16 scientific journal articles, co-authored a book chapter on point-of-care testing and holds 8 patents related to point-of-care diagnostics. He earned his bachelor’s degree in biology and chemistry did his graduate studies in microbiology, biochemistry, genetics, molecular biology and immunology.

Follow us :
Medical Device Summit 2020
Managing GMP Compliance and Phase Appropriate GMP Considerations for Virtual Companies

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed